摘要
在医药购销领域药企由赞助学术会议以贿赂医务人员谋求竞争优势的乱象频生,其原因主要是监管缺位、法律结构不完善以及从业人员自身职业道德低下等,故对之治理可在现有法律制度的基础上,借鉴外国在立法及监督方面的经验,通过立法机关、政府、医院、药企、从业人员和行业协会各方联合发力,形成监管完善、市场公开透明、企业正常运作的有效管控局面。
In the field of pharmaceutical purchase and marketing,pharmaceutical enterprises sponsor academic conferences and bribe medical staff to seek competitive advantages,and this kind of chaotic phenomena happens frequently,which mainly due to the lack of supervision,the imperfect legal structure and the low professional ethics of the employees themselves.Therefore,on the basis of the existing legal systems,we can govern it by drawing on the experiences of foreign countries in legislation and supervision,making joint efforts through the legislative organs,government,hospital and pharmaceutical enterprises,practitioners and industry associations,and forming an effective management with sound regulation,open and transparent market,and normal operation of enterprises.
作者
戴闻萱
邓勇
Dai Wenxuan;Deng Yong
出处
《医学与法学》
2021年第3期112-116,共5页
Medicine and Jurisprudence
关键词
药企
学术会议
商业贿赂
制度建设
pharmaceutical enterprise
academic conference
commercial bribery
system construction